Prominent politicians and leading nonprofit groups come together to tackle pressing issues surrounding the 340B Healthcare Program. The 340B Program is a federal initiative that requires pharmaceutical manufacturers to provide outpatient drugs at discounted prices to qualifying healthcare organizations serving uninsured and low-income patients. With the goal of improving healthcare accessibility and affordability, these experts delve into strategies aimed at enhancing transparency, streamlining facilitation processes, and addressing the critical need for comprehensive reporting within the program.